Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Improved protocol for simultaneous analysis of leukocyte subsets and epithelial cells from murine and human lung.

Happle C, Meyer-Decking L, Dreier A, Wetzke M, Gläsener S, Grychtol R, Braubach P, Jablonka A, Haid S, Jirmo AC, Habener A, Skuljec J, Hansen G.

Exp Lung Res. 2018 Apr;44(3):127-136. doi: 10.1080/01902148.2018.1432721. Epub 2018 Apr 20.

PMID:
29677457
2.

Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.

Baier C, Haid S, Beilken A, Behnert A, Wetzke M, Brown RJP, Schmitt C, Ebadi E, Hansen G, Schulz TF, Pietschmann T, Bange FC.

Antimicrob Resist Infect Control. 2018 Feb 13;7:21. doi: 10.1186/s13756-018-0316-2. eCollection 2018.

3.

Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.

Haid S, Grethe C, Bankwitz D, Grunwald T, Pietschmann T.

J Virol. 2015 Dec 30;90(6):3065-73. doi: 10.1128/JVI.03074-15.

4.

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, Schang LM, Kirschning A, Müller R, Guzman CA, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T.

Hepatology. 2016 Jan;63(1):49-62. doi: 10.1002/hep.28111. Epub 2015 Oct 9.

5.

Lower radiation burden in state of the art fluoroscopic cystography compared to direct isotope cystography in children.

Haid B, Becker T, Koen M, Berger C, Langsteger W, Gruy B, Putz E, Haid S, Oswald J.

J Pediatr Urol. 2015 Feb;11(1):35.e1-6. doi: 10.1016/j.jpurol.2014.08.015. Epub 2015 Feb 7.

PMID:
25748630
6.

Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.

Grabski E, Wappler I, Pfaender S, Steinmann E, Haid S, Dzionek A, Pietschmann T, Kalinke U.

J Virol. 2015 Mar;89(6):3200-8. doi: 10.1128/JVI.03229-14. Epub 2014 Dec 31.

7.

Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.

Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, Haid S, Catanese MT, Zeisel MB, Nicosia A, Baumert TF, Kaderali L, Pietschmann T.

J Virol. 2014 Nov;88(21):12644-55. doi: 10.1128/JVI.01145-14. Epub 2014 Aug 20.

8.

Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Hueging K, Doepke M, Vieyres G, Bankwitz D, Frentzen A, Doerrbecker J, Gumz F, Haid S, Wölk B, Kaderali L, Pietschmann T.

J Virol. 2014 Feb;88(3):1433-46. doi: 10.1128/JVI.01815-13. Epub 2013 Oct 30.

9.

Isolate-dependent use of claudins for cell entry by hepatitis C virus.

Haid S, Grethe C, Dill MT, Heim M, Kaderali L, Pietschmann T.

Hepatology. 2014 Jan;59(1):24-34.

PMID:
23775920
10.

High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.

Kügler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.

J Biol Chem. 2012 Nov 9;287(46):39224-32. doi: 10.1074/jbc.M112.393843. Epub 2012 Sep 10.

11.

MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.

Menzel N, Fischl W, Hueging K, Bankwitz D, Frentzen A, Haid S, Gentzsch J, Kaderali L, Bartenschlager R, Pietschmann T.

PLoS Pathog. 2012;8(7):e1002829. doi: 10.1371/journal.ppat.1002829. Epub 2012 Jul 26.

12.

A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.

Haid S, Novodomská A, Gentzsch J, Grethe C, Geuenich S, Bankwitz D, Chhatwal P, Jannack B, Hennebelle T, Bailleul F, Keppler OT, Poenisch M, Bartenschlager R, Hernandez C, Lemasson M, Rosenberg AR, Wong-Staal F, Davioud-Charvet E, Pietschmann T.

Gastroenterology. 2012 Jul;143(1):213-22.e5. doi: 10.1053/j.gastro.2012.03.036. Epub 2012 Mar 27.

PMID:
22465429
13.

Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.

Frentzen A, Hüging K, Bitzegeio J, Friesland M, Haid S, Gentzsch J, Hoffmann M, Lindemann D, Zimmer G, Zielecki F, Weber F, Steinmann E, Pietschmann T.

PLoS Pathog. 2011 Apr;7(4):e1002029. doi: 10.1371/journal.ppat.1002029. Epub 2011 Apr 28.

14.

Juvenile hyaline fibromatosis: focus on radiographic features in adulthood.

Slimani S, Haddouche A, Haid S, Ladjouze-Rezig A.

Rheumatol Int. 2011 Feb;31(2):273-6. doi: 10.1007/s00296-010-1583-2. Epub 2010 Jul 27.

PMID:
20661739
15.

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, Zeisel MB, Herrmann E, Iken M, Ott M, Baumert TF, Pietschmann T.

PLoS Pathog. 2010 Jul 1;6:e1000978. doi: 10.1371/journal.ppat.1000978.

16.

Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.

Haid S, Windisch MP, Bartenschlager R, Pietschmann T.

J Virol. 2010 Jan;84(2):964-75. doi: 10.1128/JVI.01504-09. Epub 2009 Nov 4.

17.

Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.

Haid S, Pietschmann T, Pécheur EI.

J Biol Chem. 2009 Jun 26;284(26):17657-67. doi: 10.1074/jbc.M109.014647. Epub 2009 May 1.

18.

[Results of vacuum sealing therapy in joint infections].

Lüdemann M, Haid S, Wülker N, Rudert M.

Z Orthop Ihre Grenzgeb. 2006 Nov-Dec;144(6):602-8. German.

PMID:
17187335
19.

Multi-step assembly pathway of the cbb3-type cytochrome c oxidase complex.

Kulajta C, Thumfart JO, Haid S, Daldal F, Koch HG.

J Mol Biol. 2006 Feb 3;355(5):989-1004. Epub 2005 Dec 1.

PMID:
16343536
20.

Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice.

Rathke-Hartlieb S, Kahle PJ, Neumann M, Ozmen L, Haid S, Okochi M, Haass C, Schulz JB.

J Neurochem. 2001 May;77(4):1181-4.

22.

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo.

Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB.

J Neurochem. 2000 May;74(5):2213-6.

23.

Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB.

J Neurosci. 2000 Dec 15;20(24):9126-34.

24.

MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1).

Soldner F, Weller M, Haid S, Beinroth S, Miller SW, Wüllner U, Davis RE, Dichgans J, Klockgether T, Schulz JB.

Exp Cell Res. 1999 Jul 10;250(1):75-85.

PMID:
10388522
25.

A look back, a look forward for the organ procurement field.

Haid SD.

Nephrol News Issues. 1997 Feb;11(2):54-5. No abstract available.

PMID:
9096470
26.

OPO financial benchmarking: a boon for donation.

Haid SD.

Nephrol News Issues. 1996 Jun;10(6):34-5. No abstract available.

PMID:
8920434
27.

Improve OPO service, improve donation.

Haid SD.

Nephrol News Issues. 1995 Aug;9(8):38. No abstract available.

PMID:
7477486
28.

What is fair and equitable in distributing organs?

Haid SD.

Nephrol News Issues. 1993 Aug;7(8):17, 20. No abstract available.

PMID:
8371788
29.

HCFA's door is open to industry on shaping OPO regulations.

Haid SD.

Nephrol News Issues. 1991 Aug;5(8):28, 34, 46. No abstract available.

PMID:
1961316
30.

HCFA oversight not a reason for panic: a proposed approach.

Haid SD.

Nephrol News Issues. 1990 Feb;4(2):16, 50. No abstract available.

PMID:
2320130
31.

Does discrimination affect transplant rates?

Haid SD, Serbin M.

Nephrol News Issues. 1989 Oct;3(10):35, 37. No abstract available.

PMID:
2812046
32.

Femoral artery laceration complicating an intertrochanteric hip fracture: a multi-disciplinary therapeutic problem.

Moss GD, Chmell S, Pillars JR Jr, Haid S, Milewski S.

Orthopedics. 1985 Dec;8(12):1511-3.

PMID:
3832037
33.

Salvage operations for malfunctioning polytetrafluoroethylene hemodialysis access grafts.

Etheredge EE, Haid SD, Maeser MN, Sicard GA, Anderson CB.

Surgery. 1983 Sep;94(3):464-70.

PMID:
6612581
34.

Significance of microbial contamination of stored cadaver kidneys.

Anderson CB, Haid SD, Hruska KA, Etheredge EA.

Arch Surg. 1978 Mar;113(3):269-71.

PMID:
25059
35.

Renal injury by companion kidney during hypothermic pulsatile perfusion.

Anderson CB, Haid SD, Hruska KA, Etheredge EE.

Surgery. 1978 Jan;83(1):72-7.

PMID:
619474
36.

Surgical treatment of nonocclusive mesenteric infarction.

Russ JE, Haid SP, Yao JS, Bergan JJ.

Am J Surg. 1977 Nov;134(5):638-42.

PMID:
920897
37.

Adverse effect of ischemic companion kidney during ex vivo renal perfusion.

Anderson CB, Haid SD, Hruska KA, Etheredge EE.

Transplant Proc. 1977 Sep;9(3):1625-7. No abstract available.

PMID:
331601
38.

Cadaver kidney characteristics and immediate renal allograft function.

Anderson CB, Sicard GA, Haid SD, Etheredge EE.

Proc Clin Dial Transplant Forum. 1977;7:7-10. No abstract available.

PMID:
356039
39.

Innovative applications of extra-anatomic reconstruction.

Haid SP, Jurayj MN, Trippel OH.

Surg Clin North Am. 1974 Feb;54(1):123-35. Review. No abstract available.

PMID:
4273532
40.

Aneurysms of the extracranial carotid artery.

Kaupp HA, Haid SP, Jurayj MN, Bergan JJ, Trippel OH.

Surgery. 1972 Dec;72(6):946-52. No abstract available.

PMID:
4564111
41.

Cystic adventitial disease of the popliteal artery.

Haid SP, Conn J Jr, Bergan JJ.

Arch Surg. 1970 Dec;101(6):765-70. No abstract available.

PMID:
5489303
42.

Mediastinal lymphoid hamartoma.

Haid SP, Shields TW.

Arch Surg. 1970 Sep;101(3):442-5. No abstract available.

PMID:
5432623
43.

Systemic effects of intestinal revascularization.

Bergan JJ, Haid SP, Conn J Jr.

Am J Surg. 1969 Feb;117(2):235-41. No abstract available.

PMID:
4304417
44.

Parathyroid cysts. Report of two cases and a review of the literature.

Haid SP, Method HL, Beal JM.

Arch Surg. 1967 Mar;94(3):421-6. No abstract available.

PMID:
6018899

Supplemental Content

Support Center